Pathologic downstaging after neoadjuvant cisplatin-based combination chemotherapy in immunohistochemistry-defined molecular subtypes of bladder cancer
Gottfrid Sjödahl(Lund University), F. Liedberg, Jonas Abrahamsson(Hôpital Saint-Michel), Karin Holmsten(Karolinska Institutet), Anders Ullén(Inserm), Claes Lindh(Karolinska Institutet), Kristina Lövgren(Lund University), Per Eriksson(Karolinska Institutet)
Cited by 4
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k